EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Rare prostate cancer histologies: detection, characteristics and treatment
Retiring This Year? Here's How To Build an Accurate Monthly Spending Estimate Before Your Last Paycheck - AOL
Closing the gap: disparities in access to and implementation of guideline-directed medical therapy for CKM syndrome
Luke Bryan's Farm Tour Delivers Millions of Meals and FFA Support
McKenzie Lake Lawyers LLP, Merchant Law Group, and Siskinds Desmeules Announce the Settlement of Yasmin and YAZ Class Action Litigation
Bayer partners with Absolute's INERA to expand biological crop nutrition in India - The Economic Times
Vividion Therapeutics Expands Clinical Development of WRN Inhibitor VVD-214 with Phase 2 Combination Study in First-Line Patients with Advanced Colorectal Cancer | Morningstar
Is Bayer (XTRA:BAYN) Undervalued As FDA Accepts KERENDIA Filing?
Switch Bioworks, Bayer Collaborate on Biological Nitrogen Fertilizer | Agri-Pulse Communications, Inc.
Talazoparib plus enzalutamide in high-volume metastatic hormone-naive prostate cancer: a randomized phase 2 trial
Bayer scales direct seeded rice push as acreage crosses 2 lakh in 2026
Bayer to distribute, market INERA's crop nutrition products
Bayer expands its direct seeded rice program to over 2 lakh acres in 2026
Assessing products to counter side effects of GLP-1, says Bayer's Triana
BAYN: Litigation Is Still Costly, Crop Execution And New Drugs Drive The Upside
Leverkusen keen to extend Maza's contract as Premier League sides circle
Bayer Moves To Expand KERENDIA Into Chronic Kidney Disease Without Diabetes
U.S. FDA Accepts Bayer's Supplemental New Drug Application for KERENDIA® (finerenone) to Treat Adults with Chronic Kidney Disease (CKD) Without Diabetes | Morningstar
The Contrast Media Market: The Invisible Hand Behind Every Clear Scan
Biopharma building innovation ecosystem
Bayer (XTRA:BAYN) Expands Ohio Pharma Capacity, Is It Still 24% Below Fair Value?
Florian Wirtz suffers biggest market value drop in Premier League
Kofane Delays Leverkusen Deal As Premier League Interest Grows
Bayer (XTRA:BAYN) Could Be 24% Undervalued As $2.2b Ohio Drug Hub Takes Shape
Bayer deepens US manufacturing push with Ohio plant plan
Zydus launches in U.S. MSN Labs generic of Bayer's PAH drug
Zydus and MSN Launch First Generic Alternative of Bayer's Adempas in the US, ETPharma
Bayer plans $2.2bn pharmaceutical manufacturing facility in Ohio, US
Bayer Unveils $2.2 Billion Manufacturing Facility in Ohio to Expand Drug Production, ETPharma
Bayer To Invest $2.2 Bln In Ohio Pharma Site, To Create 2,100 Jobs
Bayer To Invest $2.2 Bln In Ohio Pharma Manufacturing Campus
Germany's Bayer to invest $2.2 billion in US pharma site
BAYN: Legal Progress Helps, Execution Risk Still Drives The Case
Bayer to invest $2.2 B in new manufacturing site in US to create highly-skilled jobs
President Trump grants disaster relief for Ohio after August storms
Bayer to build $2.2 billion pharmaceutical plant in Ohio
Bayer to Invest $2.2 Billion in U.S. Pharma Manufacturing Expansion | Morningstar
Three-year real-world outcomes of faricimab in pretreated eyes with treatment-resistant neovascular age-related macular degeneration
South Korea Cell and Gene Therapy Manufacturing Market Forecast to 2035 | 29.56% CAGR Unlocks a USD 7.54 Billion Opportunity in CDMO Capacity and GMP Expansion
Bayer Promotes Christoph Koenen to Chief Medical Officer | Morningstar
Effects of semaglutide on kidney disease in type 2 diabetes: a randomized placebo-controlled trial
Case: Patents/Eligibility (D. Del.)
Bayer Advances Patent Suit Over Moderna, Pfizer Covid Vaccines
Bayer (XTRA:BAYN) Stock Could Be Undervalued Following FDA Priority Review News
Bayer launches MiraSOFT stool softener exclusively at CVS
Werner helicase inhibitor for advanced microsatellite instability solid tumors: a phase 1 trial
Bayer Gains FDA Priority Review For Lynkuet Label Expansion In Breast Cancer-Related Indication
Bayer: FDA Grants Priority Review To Lynkuet For New Indication
Bayer's Alka-Seltzer Collaborates with Alka Yagnik for Unique Advertising Campaign, ETBrandEquity
Use of MRI in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease - MAGNIMS consensus recommendations
Global burden of venous thromboembolism: incidence and outcome estimates of deep-vein thrombosis and pulmonary embolism
Investors pile into Bayer €2bn dual tranche hybrids
Vividion's $2 Billion Sale Price Examined by Top Delaware Court
Bayer (XTRA:BAYN) Could Be 15% Undervalued As FDA Clears KERENDIA For Type 1 Kidney Disease
Bayer field trials put innovation to the test and farmers in the driver's seat
Bayer hives off cancer drug Stivarga to Grünenthal for up to $431 million
EPA let Bayer pick dicamba safeguards, then folded them into a proposed US rule
Bayer News
CoreWeave Stock Forecast 2026–2030: Can CRWV Recover From the AI Debt Sell-Off?
Nebius Stock Price Prediction 2026–2030: Can AI Cloud Growth Justify the Cost?
Eli Lilly Stock Forecast 2026–2030: Can LLY Break Above $1,300 After Its 7% Five-Session Rally?
Is Oracle a Good Buy Right Now? Growth, Valuation and Long-Term Risks
Latest news
Show more
USD/JPY Holds Near 158 as Japan’s Trade Deficit Widens and Rate Uncertainty Persists
Netflix Stock Falls Nearly 6% After Hours as Weak Outlook Overshadows Earnings Beat
Japan and South Korea Stocks Rebound as Semiconductor Shares Lead Gains
SpaceX Stock Jumps 7.5% as AI Revenue Surges 830% and Q3 Profit Hits $4.4 Billion
Gold Price Today: XAU/USD Slips Near $4,118 as Inflation Risks Keep Fed in Focus
